Genedx Holdings Corp Receivables Turnover Ratio (WGS), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Genedx Holdings Corp   (NASDAQ: WGS)
 

Genedx Holdings Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Genedx Holdings Corp 's ability to collect accounts receivable sequentially worsen to 6.81, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Genedx Holdings 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 54 days, from 49 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 163 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 579 to 1342.

What is Receivable Turnover Ratio?
What is Genedx Holdings Corp Selling?


What is Receivable Turnover Ratio?





WGS Receivables Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Receivable Change 67.3 % 98.71 % 59.44 % 88.35 % 63.34 %
Y / Y Revenue Change 18.2 % 27.09 % 51.67 % 45.67 % 38.56 %
Receivable Turnover Ratio (TTM) 6.81 7.45 8.34 8.52 8.96
WGS's Total Ranking # 1342 # 579 # 441 # 157 # 902
Accounts Receivable average collection period days 54 49 44 43 41
Seq. Receivable Change 3.44 % 22.04 % 26.88 % 4.45 % 22.86 %
Seq. Revenue Change -16.4 % 4.93 % 14.35 % 17.84 % -10.11 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 58
Healthcare Sector # 164
Overall Market # 1342

Receivable Turnover Ratio Statistics
High Average Low
9.45 8.13 6.19
(Dec 31 2024)   (Dec 31 2023)






Financial Statements
Genedx Holdings 's Accounts Receivable $ 77 Millions Visit WGS's Balance sheet
Genedx Holdings 's Sales TTM $ 443 Millions Visit WGS's Income Statement
Sources of WGS's Revenues Visit WGS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
WGS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
WGS's Growth Rates WGS's Roa WGS's Inventory Turnover Ratio WGS's Dividend Comparisons
WGS's Profitability Ratios WGS's Roi WGS's Asset Turnover Ratio WGS's Dividend Growth
WGS's Valuation Ratios WGS's Roe WGS's Financial Strength Ratios WGS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
Escalon Medical Corp   15.15 $ 11.445  Millions$ 0.756  Millions
Nurix Therapeutics Inc   15.11 $ 71.779  Millions$ 4.750  Millions
Rosecliff Acquisition Corp I  15.05 $ 23.433  Millions$ 1.557  Millions
Lexicon Pharmaceuticals Inc   14.91 $ 69.643  Millions$ 4.670  Millions
Qhslab Inc   14.80 $ 2.775  Millions$ 0.188  Millions
Nexgel Inc   14.19 $ 10.382  Millions$ 0.732  Millions
Sutro Biopharma Inc   14.04 $ 99.608  Millions$ 7.095  Millions
Precipio inc   13.93 $ 25.831  Millions$ 1.854  Millions
China Pharma Holdings Inc  13.86 $ 3.992  Millions$ 0.288  Millions
Talkspace Inc   13.67 $ 239.269  Millions$ 17.501  Millions
Marpai Inc  13.59 $ 17.125  Millions$ 1.261  Millions
Amneal Pharmaceuticals Inc   13.56 $ 3,045.530  Millions$ 224.634  Millions
Corcept Therapeutics Inc  13.20 $ 769.096  Millions$ 58.264  Millions
Xoma Royalty Corporation  13.05 $ 48.555  Millions$ 3.720  Millions
Mannkind Corporation  13.00 $ 360.783  Millions$ 27.757  Millions
Lifestance Health Group Inc   12.74 $ 1,494.791  Millions$ 117.296  Millions
Chemed Corporation  12.73 $ 2,540.548  Millions$ 199.626  Millions
Milestone Scientific Inc   12.69 $ 8.337  Millions$ 0.657  Millions
Lftd Partners Inc   12.55 $ 36.955  Millions$ 2.945  Millions
Clene Inc   12.47 $ 0.134  Millions$ 0.011  Millions
Skinhealth Systems Inc   12.27 $ 295.223  Millions$ 24.052  Millions
Cytokinetics Incorporated  12.16 $ 105.815  Millions$ 8.702  Millions
Precision Biosciences Inc  11.94 $ 45.073  Millions$ 3.776  Millions
Teladoc Health Inc   11.94 $ 2,514.453  Millions$ 210.660  Millions
Option Care Health Inc   11.65 $ 5,666.577  Millions$ 486.439  Millions
Ensysce Biosciences Inc   11.55 $ 4.708  Millions$ 0.407  Millions
Crinetics Pharmaceuticals Inc   11.52 $ 18.069  Millions$ 1.569  Millions
Icu Medical Inc  11.46 $ 2,156.379  Millions$ 188.157  Millions
Nrc Health  11.42 $ 138.642  Millions$ 12.138  Millions
Nuvation Bio Inc   11.41 $ 142.121  Millions$ 12.454  Millions

Date modified: 2026-08-29T17:43:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.